ArriVent reports phase 1 data for cancer drug ARR-217

Allied Gold’s 2027 Outlook: Why an Ethiopian Mine Ramping Toward 300,000 Ounces a Year Could Change Everything

NASDAQ · Markets 9m ago

Why This Hair Restoration Biotech's Shares Are Soaring

NASDAQ · Markets 9m ago

Medpace CEO August Troendle sells $1.59 million in stock

Investing.com · News 13m ago

History Says This ETF Could Be the Biggest Winner of the Stock Market Sell-Off

NASDAQ · Markets 24m ago

Earnings flood, Fed meeting will test rickety AI market rally

Investing.com · News 29m ago

Can GE Vernova's Gas Turbines Make Up for a Collapsing Wind Business?

NASDAQ · Markets 39m ago

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 2.65%

Investing.com · News 44m ago

Here's What a $10,000 Investment in Palantir Could Be Worth in 10 Years

NASDAQ · Markets 49m ago

UK’s Rayner says no Brexit reopening as Burnham floats EU free movement

Investing.com · News 50m ago

UK’s Rayner says no Brexit reopening as Burnham floats EU free movement

Investing.com · Investing_news 50m ago